Cargando…
Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142028/ https://www.ncbi.nlm.nih.gov/pubmed/21788641 http://dx.doi.org/10.2337/dc11-0756 |
| _version_ | 1782208778628759552 |
|---|---|
| author | Khalangot, Mykola D. |
| author_facet | Khalangot, Mykola D. |
| author_sort | Khalangot, Mykola D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3142028 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31420282012-08-01 Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229 Khalangot, Mykola D. Diabetes Care Diabetes Care Electronic Pages American Diabetes Association 2011-08 2011-07-16 /pmc/articles/PMC3142028/ /pubmed/21788641 http://dx.doi.org/10.2337/dc11-0756 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Diabetes Care Electronic Pages Khalangot, Mykola D. Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229 |
| title | Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229 |
| title_full | Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229 |
| title_fullStr | Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229 |
| title_full_unstemmed | Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229 |
| title_short | Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229 |
| title_sort | comment on: pantalone et al. the risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. diabetes care 2010;33:1224–1229 |
| topic | Diabetes Care Electronic Pages |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142028/ https://www.ncbi.nlm.nih.gov/pubmed/21788641 http://dx.doi.org/10.2337/dc11-0756 |
| work_keys_str_mv | AT khalangotmykolad commentonpantaloneetaltheriskofoverallmortalityinpatientswithtype2diabetesreceivingglipizideglyburideorglimepiridemonotherapyaretrospectiveanalysisdiabetescare20103312241229 |